WorldPingMerck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
This is a short WorldPing brief. The full report was published by NPR Health.
Read the full report at NPR Health
WorldPingUrologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.
Brief by WorldPing · Original reporting by STAT
"These trials are often compared to the Big Tobacco lawsuits of the 90s, and the outcome will likely be analogous as well," one analyst told CNBC.
Brief by WorldPing · Original reporting by CNBC World
The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.
Brief by WorldPing · Original reporting by CNBC
WorldPingSources close to the Sussexes have not denied reports that Meghan has been offered an acting role in the UK.
Brief by WorldPing · Original reporting by BBC Culture
WorldPingNew research suggests that if dark matter is composed of "dark photons," it would not have heated the early cosmos like scientists thought.
Brief by WorldPing · Original reporting by Space.com
WorldPingUS drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough.
Brief by WorldPing · Original reporting by France 24
WorldPing